These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9257335)

  • 21. Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.
    Kroll T; Elmenhorst D; Matusch A; Wedekind F; Weisshaupt A; Beer S; Bauer A
    Mol Imaging Biol; 2013 Aug; 15(4):456-67. PubMed ID: 23456885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of 5HT2A receptors in the human brain: comparison of data in vivo and post mortem.
    Forutan F; Estalji S; Beu M; Nikolaus S; Hamacher K; Coenen HH; Vosberg H; Müller-Gärtner HW; Larisch R
    Nuklearmedizin; 2002; 41(4):197-201. PubMed ID: 12224404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
    Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
    Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge.
    Pinborg LH; Adams KH; Yndgaard S; Hasselbalch SG; Holm S; Kristiansen H; Paulson OB; Knudsen GM
    J Cereb Blood Flow Metab; 2004 Sep; 24(9):1037-45. PubMed ID: 15356424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction.
    Meltzer CC; Smith G; Price JC; Reynolds CF; Mathis CA; Greer P; Lopresti B; Mintun MA; Pollock BG; Ben-Eliezer D; Cantwell MN; Kaye W; DeKosky ST
    Brain Res; 1998 Nov; 813(1):167-71. PubMed ID: 9824691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex difference in 5HT2 receptor in the living human brain.
    Biver F; Lotstra F; Monclus M; Wikler D; Damhaut P; Mendlewicz J; Goldman S
    Neurosci Lett; 1996 Feb; 204(1-2):25-8. PubMed ID: 8929969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of changes in endogenous serotonin level by positron emission tomography with [
    Ikoma Y; Takuwa H; Nishino A; Maeda J; Kawamura K; Obata T; Zhang MR; Higuchi M; Suhara T
    Ann Nucl Med; 2021 Aug; 35(8):955-965. PubMed ID: 34101154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
    López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):446-54. PubMed ID: 9349630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of brain 5HT2 receptor binding potential with a single-dose PET paradigm.
    Petit Taboué MC; Baron JC
    Eur J Nucl Med; 1995 Jun; 22(6):585-6. PubMed ID: 7556308
    [No Abstract]   [Full Text] [Related]  

  • 30. Distinct autoradiographic labelling of serotonin 5-HT2 receptors, alpha 1-adrenoceptors and histamine-H1 receptors and of tetrabenazine-displaceable ketanserin binding sites in rodent brain with [125I]7-amino-8-iodo-ketanserin.
    Schotte A; Leysen JE
    Eur J Pharmacol; 1988 Jan; 145(2):213-6. PubMed ID: 2832189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans.
    Price JC; Lopresti BJ; Meltzer CC; Smith GS; Mason NS; Huang Y; Holt DP; Gunn RN; Mathis CA
    Synapse; 2001 Jul; 41(1):11-21. PubMed ID: 11354009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of [(18)F]altanserin and [(18)F]deuteroaltanserin for PET imaging of serotonin(2A) receptors in baboon brain: pharmacological studies.
    Staley JK; Van Dyck CH; Tan PZ; Al Tikriti M; Ramsby Q; Klump H; Ng C; Garg P; Soufer R; Baldwin RM; Innis RB
    Nucl Med Biol; 2001 Apr; 28(3):271-9. PubMed ID: 11323237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo.
    Blin J; Pappata S; Kiyosawa M; Crouzel C; Baron JC
    Eur J Pharmacol; 1988 Feb; 147(1):73-82. PubMed ID: 3259509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography.
    Quednow BB; Treyer V; Hasler F; Dörig N; Wyss MT; Burger C; Rentsch KM; Westera G; Schubiger PA; Buck A; Vollenweider FX
    Neuroimage; 2012 Feb; 59(4):3922-32. PubMed ID: 21996132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex.
    Biver F; Wikler D; Lotstra F; Damhaut P; Goldman S; Mendlewicz J
    Br J Psychiatry; 1997 Nov; 171():444-8. PubMed ID: 9463603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation and quantification of [18F]altanserin binding in the rat brain using blood input and reference tissue modeling.
    Riss PJ; Hong YT; Williamson D; Caprioli D; Sitnikov S; Ferrari V; Sawiak SJ; Baron JC; Dalley JW; Fryer TD; Aigbirhio FI
    J Cereb Blood Flow Metab; 2011 Dec; 31(12):2334-42. PubMed ID: 21750562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans.
    Matusch A; Hurlemann R; Rota Kops E; Winz OH; Elmenhorst D; Herzog H; Zilles K; Bauer A
    J Neural Transm (Vienna); 2007; 114(11):1433-42. PubMed ID: 17541696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
    Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats.
    Plenevaux A; Weissmann D; Aerts J; Lemaire C; Brihaye C; Degueldre C; Le Bars D; Comar D; Pujol J; Luxen A
    J Neurochem; 2000 Aug; 75(2):803-11. PubMed ID: 10899958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.